MetaADEDB 2.0 @ LMMD
Kombiglyze XR
(QUKZWYNGKYRRKE-RIKNOMPASA-N)
Structure
SMILES
CN(C(=N)N=C(N)N)C.N#C[C@H]1CC2[C@H](N1C(=O)[C@@H](C13CC4CC(C1)CC(C3)(C4)O)N)C2
Molecular Formula:
C22H36N8O2
Molecular Weight:
444.574
Log P:
2.0527
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
5
TPSA:
181.84
CAS Number(s):
1198772-17-6
Synonym(s)
1.
Kombiglyze XR
External Link(s)
PubChem Compound56842229
Therapeutic Target DatabaseD05IPF
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood glucose increasedFAERS: 38US FAERS
2Drug ineffectiveFAERS: 35US FAERS
3NauseaFAERS: 35US FAERS
4PancreatitisFAERS: 30US FAERS
5VomitingFAERS: 26US FAERS
6DizzinessFAERS: 25US FAERS
7Medication residue presentFAERS: 25US FAERS
8Drug dose omissionFAERS: 22US FAERS
9Abdominal discomfortFAERS: 19US FAERS
10HeadacheFAERS: 17US FAERS
11MalaiseFAERS: 14US FAERS
12PruritusFAERS: 14US FAERS
13Weight decreasedFAERS: 13US FAERS
14Abdominal PainFAERS: 12US FAERS
15MyalgiaFAERS: 12US FAERS
16Chest PainFAERS: 11US FAERS
17Medication residueFAERS: 11US FAERS
18UrticariaFAERS: 11US FAERS
19ConstipationFAERS: 10US FAERS
20FatigueFAERS: 9US FAERS
21PalpitationsFAERS: 8US FAERS
22Blood creatinine increasedFAERS: 7US FAERS
23HypersensitivityFAERS: 7US FAERS
24DyspepsiaFAERS: 6US FAERS
25Medication ErrorFAERS: 6US FAERS
26Adverse eventFAERS: 5US FAERS
27ArthralgiaFAERS: 5US FAERS
28AstheniaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Blood glucose abnormalFAERS: 5US FAERS
30Intentional product misuseFAERS: 5US FAERS
31PainFAERS: 5US FAERS
32SomnolenceFAERS: 5US FAERS
33Back PainFAERS: 4US FAERS
34Blood glucose fluctuationFAERS: 4US FAERS
35Cerebrovascular accidentFAERS: 4US FAERS
36Circumstance or information capable of leading to medication errorFAERS: 4US FAERS
37DehydrationFAERS: 4US FAERS
38DysuriaFAERS: 4US FAERS
39Pancreatic carcinomaFAERS: 4US FAERS
40TremorFAERS: 4US FAERS
41Visual ImpairmentFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
42AlopeciaFAERS: 3US FAERS
43Blood glucose decreasedFAERS: 3US FAERS
44Creatinine renal clearance increasedFAERS: 3US FAERS
45Diabetes mellitus inadequate controlFAERS: 3US FAERS
46Drug administration errorFAERS: 3US FAERS
47FlatulenceFAERS: 3US FAERS
48Musculoskeletal PainFAERS: 3US FAERS
49Neck PainFAERS: 3US FAERS
50NephrolithiasisFAERS: 3US FAERS
51Peripheral swellingFAERS: 3US FAERS
52PneumoniaFAERS: 3US FAERS
53Product quality issueFAERS: 3US FAERS
54AcidosisFAERS: 2US FAERS
55Anaphylactic shockFAERS: 2US FAERS
56AngioedemaFAERS: 2US FAERS
57ArthritisFAERS: 2US FAERS
58Blood triglycerides increasedFAERS: 2US FAERS
59Bone painFAERS: 2US FAERS
60Chest discomfortFAERS: 2US FAERS
61CystitisFAERS: 2US FAERS
62Drug prescribing errorFAERS: 2US FAERS
63DysgeusiaFAERS: 2US FAERS
64ErythemaFAERS: 2US FAERS
65Feeling abnormalFAERS: 2US FAERS
66Hypertensive crisisFAERS: 2US FAERS
67Inability to afford medicationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Incorrect dose administeredFAERS: 2US FAERS
69Lipase increasedFAERS: 2US FAERS
70Memory impairmentFAERS: 2US FAERS
71Myocardial InfarctionFAERS: 2US FAERS
72NasopharyngitisFAERS: 2US FAERS
73RetchingFAERS: 2US FAERS
74SyncopeFAERS: 2US FAERS
75Urinary tract infectionFAERS: 2US FAERS
76furuncleFAERS: 2US FAERS
77Abdominal AbscessFAERS: 1US FAERS
78Acute left ventricular failureFAERS: 1US FAERS
79AgeusiaFAERS: 1US FAERS
80Amylase increasedFAERS: 1US FAERS
81AnxietyFAERS: 1US FAERS
82Bladder painFAERS: 1US FAERS
83Blood cholesterol increasedFAERS: 1US FAERS
84Blood creatine phosphokinase abnormalFAERS: 1US FAERS
85Blood pressure inadequately controlledFAERS: 1US FAERS
86Blood testosterone increasedFAERS: 1US FAERS
87Blood urea increasedFAERS: 1US FAERS
88Cardiac ArrestFAERS: 1US FAERS
89CataractFAERS: 1US FAERS
90Cerebrovascular InsufficiencyFAERS: 1US FAERS
91CholangiocarcinomaFAERS: 1US FAERS
92ChromaturiaFAERS: 1US FAERS
93Circumstance or information capable of leading to device use errorFAERS: 1US FAERS
94DementiaFAERS: 1US FAERS
95Diabetes MellitusFAERS: 1US FAERS
96Diabetic KetoacidosisFAERS: 1US FAERS
97Diabetic NephropathyFAERS: 1US FAERS
98Drug dispensing errorFAERS: 1US FAERS
99Ear discomfortFAERS: 1US FAERS
100Emotional distressFAERS: 1US FAERS
101EpistaxisFAERS: 1US FAERS
102Extra dose administeredFAERS: 1US FAERS
103Feeling ColdFAERS: 1US FAERS
104Fibrin D dimer increasedFAERS: 1US FAERS
105Flank PainFAERS: 1US FAERS
106FlushingFAERS: 1US FAERS
107GastritisFAERS: 1US FAERS
108GastroenteritisFAERS: 1US FAERS
109Genital swellingFAERS: 1US FAERS
110HepatitisFAERS: 1US FAERS
111HungerFAERS: 1US FAERS
112HypophagiaFAERS: 1US FAERS
113Inappropriate schedule of drug administrationFAERS: 1US FAERS
114Insurance issueFAERS: 1US FAERS
115KetoacidosisFAERS: 1US FAERS
116LaryngitisFAERS: 1US FAERS
117Limb discomfortFAERS: 1US FAERS
118Limb injuryFAERS: 1US FAERS
119Lip swellingFAERS: 1US FAERS
120MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
121Mood swingsFAERS: 1US FAERS
122Nerve injuryFAERS: 1US FAERS
123NervousnessFAERS: 1US FAERS
124Night sweatsFAERS: 1US FAERS
125NoduleFAERS: 1US FAERS
126ObesityFAERS: 1US FAERS
127Oropharyngeal painFAERS: 1US FAERS
128OverweightFAERS: 1US FAERS
129Pancreatic enzymes increasedFAERS: 1US FAERS
130Peripheral arterial occlusive diseaseFAERS: 1US FAERS
131PlasmapheresisFAERS: 1US FAERS
132Product dose omissionFAERS: 1US FAERS
133Product lot number issueFAERS: 1US FAERS
134Product packaging issueFAERS: 1US FAERS
135Product physical issueFAERS: 1US FAERS
136Product solubility abnormalFAERS: 1US FAERS
137PsoriasisFAERS: 1US FAERS
138Pubic painFAERS: 1US FAERS
139RhabdomyolysisFAERS: 1US FAERS
140SepsisFAERS: 1US FAERS
141Stevens-Johnson SyndromeFAERS: 1US FAERS
142StressFAERS: 1US FAERS
143Sudden Cardiac DeathFAERS: 1US FAERS
144SwellingFAERS: 1US FAERS
145Therapeutic response unexpectedFAERS: 1US FAERS
146Therapy cessationFAERS: 1US FAERS
147ThrombocytopeniaFAERS: 1US FAERS
148Thyroglobulin increasedFAERS: 1US FAERS
149Wrong technique in drug usage processFAERS: 1US FAERS
150nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.